HIC
TXG icon

Hamrick Investment Counsel’s 10x Genomics TXG Stock Holding History

Hamrick Investment Counsel’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-120
Closed -$2.55K – 329
2026
Q1 		$2.55K Buy
+120
New +$2.4K ﹤0.01% 303

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Hamrick Investment Counsel's TXG Position: Q2 2026 in Review

Hamrick Investment Counsel sold out of 10x Genomics (TXG) in Q2 2026, closing a stake of 120 shares — an estimated $2.55K sold.

Hamrick Investment Counsel first reported a position in TXG in Q1 2026 and held it in 1 quarter. The position peaked at $2.55K in Q1 2026. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.

  • Hamrick Investment Counsel reported no remaining 10x Genomics position as of Q2 2026 after selling out during the quarter.
  • Hamrick Investment Counsel sold 120 10x Genomics shares in Q2 2026, an estimated $2.55K.
  • Hamrick Investment Counsel first reported a position in 10x Genomics in Q1 2026 and held it in 1 quarter.
  • Hamrick Investment Counsel's 10x Genomics position peaked at $2.55K in Q1 2026.
  • 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.

Based on Hamrick Investment Counsel's 13F filing for Q2 2026, filed 13 Aug 2026.